MMMark A. McCoy

Mark A. McCoy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mark A. McCoy has a total of 180 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Monitoring Liraglutide Oligomeric Interconversion and Fibril Dissociation through High-Pressure NMR Spectroscopy

    by Xingjian Xu, Pablo Trigo-Mouriño, Qi Gao, Yingkai Liang, Mark A. McCoy, Mikhail Reibarkh

    Aggregation and conformational dynamics are key attributes influencing the quality of peptide and protein therapeutics, yet the oligomerization pathways that underlie these behaviors remain difficult to characterize with conventional analytical tools. Here, we establish high-pressure nuclear magnetic resonance (HP-NMR) as the centerpiece of an integrated analytical strategy for probing the aggregation landscape of peptide therapeutics in aqueous formulations. Using liraglutide, a GLP-1 receptor agonist with well-documented but incompletely resolved self-assembly behavior, as a model system, we demonstrate that hydrostatic pressure reversibly modulates interconversion between its two distinct oligomeric states and dissociates fibrils, enabling direct, nondestructive delineation of oligomer exchange and fibrillation pathways under controlled conditions. Flow-NMR is also introduced as a complementary tool that provides independent control over fibrillation kinetics, further expanding the analytical toolkit. Together, these approaches yield thermodynamic and kinetic parameters, such as apparent free-energy differences and partial molar volume changes that are inaccessible by conventional biophysical methods, offering a rigorous and generalizable framework for characterizing aggregation-prone drug modalities.

  • A Dehydration–Diffusion Competition Framework Predicts Interfacial Film Risk in High-Concentration Biologics Fill-Finish

    by Yu-Jiun Lin, Ruomeng Qiu, Qi Gao, Yu Tian, Iriny Ekladious, Mark McCoy, Katelyn Smith, Hanmi Xi, Adam Procopio, Wei Xu

    High-concentration protein formulations are increasingly demanded for the development of subcutaneous injections owing to its clinical and commercial advantages. However, their high protein concentrations can lead to dried residues, causing failures in manufacturing operations such as piston pump seizing and filling needle clogging. Transient dehydration during fill-finish holds can generate interfacial viscoelastic films that resist redissolution and perturb delivery performance. Here, we establish an operational framework that links dehydration exposure to film mechanics and reversibility for high-concentration biologics. Using a bench-scale apparatus with controlled airflow, we observe orders-of-magnitude increases in interfacial storage modulus (G') with accumulated mass loss (m) and identify conditions where films fail to fully redissolve on minutes time scales. We define four portable readouts, maximum film strength (GM'), final film strength (GF'), imbibition time (tImb), and dissolving time (tDis)─to translate viscoelastic traces into process decision variables. Normalization by hydrodynamic volume fraction (ϕhyd) exposes two packing thresholds that organize mechanics and kinetics: a transition near random loose packing (RLP, ϕRLP ≈0.56), where percolation limits rearrangement and attenuates growth of GM', and a second near random close packing (RCP, ϕRCP ≈0.64), where bulk jamming undercuts further strengthening and slows film disintegration. Consistently, tImb steeply scales once mass loss approaches ∼30% (mapping toward RCP), while tDis reflects a protein diffusion-dominated recovery. A critical ∼52-55% mass-loss window marks a sharp rise in GF' and elastic persistence (G' > G″) after imbibition, indicating conditional irreversibility on process time scales. Together, these results yield an actionable "no-film/at-risk" map indexed to exposure dehydration flux, time, and formulation, providing quantitative limits for downtime and rewet strategies in fill-finish.


  • Development of Flow-NMR Spectroscopy for Real-Time Monitoring and Kinetics Studies of Biomolecules: Case Study of Liraglutide Oligomerization

    by Xingjian Xu, Guilherme Dal Poggetto, Yingkai Liang, Pablo Trigo-Mouriño, Peter G. Dormer, Yining Ji, Keith A. Mattern, Mark A. McCoy, Mikhail Reibarkh, Qi Gao

    We report the development of a comprehensive flow-NMR methodology for mechanistic studies of biomolecules. This approach allows for systematic kinetic investigation via precise sample condition modulations. Traditionally utilized for reaction monitoring and kinetic studies of small molecules, the application of flow-NMR to larger biomolecules, such as peptide oligomers and proteins, has remained unexplored. Here, we present a pioneering study using flow-NMR to examine the pH-dependent oligomeric interconversion of liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist known for its efficacy in managing type 2 diabetes and obesity. Liraglutide molecules are prone to forming distinct oligomers and even fibrils under certain conditions, influencing their stability, absorption, and bioavailability─factors critically important in pharmaceutical applications. The developed methodologies and suite of flow-NMR experiments collectively yield comprehensive insights into the interconversion process of liraglutide without resorting to combining multiple other techniques. It incorporates various 1D and pseudo-2D proton NMR experiments, including GUPPY-DOSY, a newly developed version of a flow-compatible DOSY experiment, to monitor critical parameters such as diffusion coefficients (D), transverse relaxation (R2), and structural similarity. The relative ease of setting up and executing this set of flow-NMR experiments offers a straightforward path to extending their application to the characterization of other complex systems, including therapeutic proteins and biologic drugs.


  • Rapid Characterization of Structural and Behavioral Changes of Therapeutic Proteins by Relaxation and Diffusion 1H-SOFAST NMR Experiments

    by Xingjian Xu, Guilherme Dal Poggetto, Mark McCoy, Mikhail Reibarkh, Pablo Trigo-Mourino

    Biologic drugs have emerged as a rapidly expanding and important modality, offering promising therapeutic solutions by interacting with previously "undruggable" targets, thus significantly expanding the range of modern pharmaceutical applications. However, the inherent complexity of these drugs also introduces liabilities and poses challenges in their development, necessitating efficient screening methods to evaluate the structural stability and behavior. Although nuclear magnetic resonance (NMR) spectroscopy is well-suited for detecting weak interactions, changes in dynamics, high-order structure, and association states of macromolecules in fully formulated samples, the inherent low sensitivity limits its utility as a fast screening and characterization tool. In this study, we present two fast pulsing NMR experiments, namely the band-Selective Optimized Flip-Angle Internally encoded Relaxation (SOFAIR) and the band-Selective Optimized Flip-angle Internally encoded Translational diffusion (SOFIT)), which enable rapid and reliable measurements of transverse relaxation rates and diffusion coefficients with more than 10-fold higher sensitivity compared to commonly used methods, like Carr-Purcell-Meiboom-Gill and diffusion-ordered spectroscopy, allowing the rapid assessment of biologics even at low concentrations. We demonstrated the effectiveness and versatility of these experiments by evaluating several examples, including thermally stressed proteins, proteins at different concentrations, and a therapeutic protein in various formulations. We anticipate that these novel approaches will greatly facilitate the analysis and characterization of biologics during drug discovery.


  • Open Access

    Biostructural, biochemical and biophysical studies of mutant IDH1

    by Mark A. McCoy, Jun Lu, F. Richard Miller, Stephen M. Soisson, Michael H. Lam, Christian Fischer

    We report bio-structural, bio-chemical and bio-physical evidence demonstrating how small molecules can bind to both wild-type and mutant IDH1, but only inhibit the enzymatic activity of the mutant isoform. Enabled through x-ray crystallography, we characterized a series of small molecule inhibitors that bound to mutant IDH1 differently than the marketed inhibitor Ivosidenib, for which we have determined the x-ray crystal structure. Across the industry several mutant IDH1 inhibitor chemotypes bind to this allosteric IDH1 pocket and selectively inhibit the mutant enzyme. Detailed characterization by a variety of biophysical techniques and NMR studies led us to propose how compounds binding in the allosteric IDH1 R132H pocket inhibit the production of 2-Hydroxy glutarate.


  • Open Access

    Rapid Characterization of Structural and Behavioral Changes of Therapeutic Proteins by Relaxation and Diffusion 1H-SOFAST NMR Experiments

    by Xingjian Xu, Guilherme Dal Poggetto, Mark McCoy, Mikhail Reibarkh, Pablo Trigo Mourino

    Biologic drugs have emerged as a rapidly expanding and important modality, offering promising therapeutic solutions by interacting with previously 'undruggable' targets, thus significantly expanding the range of modern pharmaceutical applications. However, the inherent complexity of these drugs also introduces liabilities and poses challenges in their development, necessitates efficient screening methods to evaluate the structural stability and behavior. Although NMR spectroscopy is well-suited for detecting weak interactions, changes in dynamics, high-order structure, and association states of macromolecules in fully formulated samples, the inherent low sensitivity limits its utility as a fast screening and characterization tool. In this study, we present two fast pulsing NMR experiments, namely the SOFAIR (band-Selective Optimized Flip-Angle Internally-encoded Relaxation) and the SOFIT (band-Selective Optimized Flip-angle Internally-encoded Translational diffusion), which enable rapid and reliable measurements of transverse relaxation rates and diffusion coefficients with more than 10-fold higher sensitivity compared to commonly used methods, like CPMG (Carr-Purcell-Meiboom-Gill) and DOSY (Diffusion-Ordered Spectroscopy), allowing the rapid assessment of biologics even at low concentrations. We demonstrated the effectiveness and versatility of these experiments by evaluating several examples, including thermally stressed proteins, proteins at different concentrations, and a therapeutic protein in various formulations. We anticipate that these novel approaches will greatly facilitate the analysis and characterization of biologics during drug discovery.


  • High-Throughput Fluorometric Assay For Quantifying Polysorbate In Biopharmaceutical Products Using Micelle Activated Fluorescence Probe N-Phenyl-1-Naphthylamine

    by Ximeng Y. Dow, Qi Gao, John L. Sperduto, Xiaona Wen, Christopher Thai, Lei Zhang, Mark A. McCoy

    Purpose Polysorbates are among the most used surfactants in biopharmaceutical products containing proteins. Our work aims to develop a high-throughput fluorometric assay to further diversify the analytical toolbox for quantification of PSs. Method The assay leverages the micelle activated fluorescence signal from N-Phenyl-1-Naphthylamine (NPN). The development and optimization of assay parameters were guided by the pre-defined analytical target profile. Furthermore, NMR was used to probe the interaction between protein, PS80 and NPN in the measurement system and understand protein interference. Results All assay parameters including excitation and emission wavelengths, standard curve, NPN concentration, and incubation time have been optimized and adapted to a microplate format, making it compatible with automated solutions that will be pursued in the near future to drive consistency and efficiency in our workflows. The specificity, accuracy, and precision of the assay have been demonstrated through a case study. Furthermore, NMR results provided additional insight into the change of the interaction dynamics between PS80 and NPN as the protein concentration increases. The results indicate minimal interaction between the protein and PS80 at lower concentration. However, when the concentration exceeds 75 mg/mL, there is a significant interaction between the protein and PS-80 micelle and monomer. Conclusion A high-throughput fluorometric assay has been developed for quantification of polysorbates in biopharmaceutical samples including in-process samples, drug substance and drug product. The assay reported herein could serve as a powerful analytical tool for polysorbate quantification and control, complementing the widely used liquid chromatography with charged aerosol detection method.


  • Open Access

    Investigating protein–excipient interactions of a multivalent V HH therapeutic protein using NMR spectroscopy

    by Jainik Panchal, Bradley T. Falk, Valentyn Antochshuk, Mark A. McCoy

    Multispecific therapeutic proteins come in a variety of formats, including bi- and tri-specific antibodies, dual-variable domain antibodies, and CrossMabs. These multivalent proteins are engineered to interact with multiple therapeutic target proteins with high specificity. Multi-domain proteins can be created by linking together a variety of high-affinity antibody fragments. The choice of protein domains and linkers not only affects the interactions of these molecules with therapeutic targets but also influences the intrinsic behavior in solution that affects their stability. The complexity of solution interactions may translate into developability and manufacturing challenges. Here, we use nuclear magnetic resonance (NMR) spectroscopy to study the solution behavior of a multivalent VHH molecule composed of three flexibly linked heavy-chain-only domains that show dramatic stabilization against thermal degradation in the presence of sucrose. A collection of NMR fingerprinting and profiling methods were used to simultaneously monitor the protein solution behavior and capture details of protein–excipient interactions. We provide a framework to characterize and begin to understand the role of molecular flexibility in protein stabilization with potential applications in the design of novel therapeutic protein scaffolds that include multivalent proteins, fusion proteins, antibody-drug conjugates, and proteins modified with flexible lipids.


  • Molecular Mechanism of Antimicrobial Excipient-Induced Aggregation in Parenteral Formulations of Peptide Therapeutics

    by Mingyue Li, Bradley T. Falk, Xingyu Lu, Ryan Schroder, Mark Mccoy, Wei Xu, Daniel H. Yin, Marian E. Gindy, Suzanne M. D’aDdio, Yongchao Su

    Antimicrobial preservatives are used as functional excipients in multidose formulations of biological therapeutics to destroy or inhibit the growth of microbial contaminants, which may be introduced by repeatedly administering doses. Antimicrobial agents can also induce the biophysical instability of proteins and peptides, which presents a challenge in optimizing the drug product formulation. Elucidating the structural basis for aggregation aids in understanding the underlying mechanism and can offer valuable knowledge and rationale for designing drug substances and drug products; however, this remains largely unexplored due to the lack of high-resolution characterization. In this work, we utilize solution nuclear magnetic resonance (NMR) as an advanced biophysical tool to study an acylated 31-residue peptide, acyl-peptide A, and its interaction with commonly used antimicrobial agents, benzyl alcohol and m-cresol. Our results suggest that acyl-peptide A forms soluble octamers in the aqueous solution, which tumble slowly due to an increased molecular weight as measured by diffusion ordered spectroscopy and H-1 relaxation measurement. The addition of benzyl alcohol does not induce aggregation of acyl-peptide A and has no chemical shift perturbation in H-1-H-1 NOESY spectra, suggesting no detectable interaction with the peptide. In contrast, the addition of 1% (w/v) m-cresol results in insoluble aggregates composed of 25% (w/w) peptides after a 24-hour incubation at room temperature as quantified by H-1 NMR. Interestingly, H-1-C-13 heteronuclear single-quantum coherence and H-1-H-1 total correlation experiment spectroscopy have identified m-cresol and peptide interactions at specific residues, including Met, Lys, Glu, and Gln, suggesting that there may be a combination of hydrophobic, hydrogen bonding, and electrostatic interactions with m-cresol driving this phenomenon. These site-specific interactions have promoted the formation of higher-order oligomerization such as dimers and trimers of octamers, eventually resulting in insoluble aggregates. Our study has elucidated a structural basis of m-cresol-induced self association that can inform the optimized design of drug substances and products. Moreover, it has demonstrated solution NMR as a high-resolution tool to investigate the structure and dynamics of biological drug products and provide an understanding of excipientinduced peptide and protein aggregation.


  • Open Access

    Mechanistic insights on novel small molecule allosteric activators of cGMP-dependent protein kinase PKG1α

    by Paul Tawa, Lei Zhang, Essam Metwally, Yan Hou, Mark A. McCoy, W. Michael Seganish, Rumin Zhang, Emily Frank, Payal Sheth, Jennifer Hanisak, et al.